Real-world experience, they report, shows interstitial-lung-disease rates below 10 %, alopecia at single digits, and nausea/fatigue as the principal AEs. The experts comment that the AEs are easily manageable thanks to dexamethasone and olanzapine. The take-home: today’s oncologist must the same quality-of-life AEs, i.e. fatigue and N/V while still scanning lungs for ILD.
T-DXd Tolerability: Evidence vs. RWE
Recommended Videos
